Popular Articles

Mercury In Mackenzie River Delta Dramatically Higher Than Previously Believed
University of Alberta researchers conducting a water study in the Mackenzie River Delta have found a dramatically higher delivery of mercury from the Mackenzie River to the Arctic Ocean than determined in previous studies.
generic viagra online
Superfood Soy Linked To Reduction In Smoker's Lung Damage Risk
People who eat lots of soy products have better lung function and are less likely to develop the smoking-associated lung disease COPD (Chronic Obstructive Pulmonary Disease). A study published in BioMed Central"s open access journal Respiratory Research has shown that consumption of a wide variety of soy products can be associated with a reduction in the risk of COPD and other respiratory symptoms.
News of the day
QuantRx Announces FluoroPharma To Present Phase I Study Results Of Novel Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) Tracer
QuantRx® Biomedical Corporation (OTCBB:QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, announced that its affiliate, FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, will present Phase I data relating to the safety, dosimetry, and pharmacokinetics in human subjects of BFPET, its novel 18-F labeled (PET) tracer for myocardial perfusion imaging, at the Society of Nuclear Medicine 2009 Annual Meeting in Toronto.
Medical Devices

APEX Guides: Helping PBC Leaders To Become World Class Commissioners

The first three guides - Clinical Engagement, Governance and Prioritising Investment - will be launched at the Practice Based Commissioning National Forum, on 1 July. A fourth guide, on Patient and Public Engagement, will be published over the summer and a fifth, on Procurement, is already in the pipeline and expected to be published in September. APEX recognises that commissioners will have to make tough decisions to bring costs down while focusing on quality. Practice-based commissioning will be crucial in this process by bringing Primary Care Trusts (PCTs) and clinicians together. Dr David Jenner, Practice Based Federation Lead, NHS Alliance, said: "We want to promote the partnership between PBC and PCTs through effective commissioning. The APEX guides will help practice based commissioners develop to become world class commissioners with their PCTs by demonstrating what true world class commissioning would look like in action." Mark Hill, co-chair for APEX and Market Access Director at Novartis UK, said: "I am delighted that Novartis have collaborated with the NHS Alliance to develop these innovative commissioning competency guides. I firmly believe that the APEX guides will foster a productive relationship between PBC and PCTs and help to drive and deliver excellence in WCC". All guides are being developed through focus groups and discussions with key health service professionals. APEX is also currently developing a website which will become a platform for commissioners to share their experience and examples of best practice. NHSA members can download free copies of the guides from the NHS Alliance"s website at http://www.nhsalliance.org Notes 1. APEX is a practical, collaborative network, driving best practice and catalysing positive change for patients through practice-based commissioning (PBC). The APEX membership comprises a multidisciplinary group of PBC leaders who are representative of SHAs, and includes local PBC Group Chairs, SHA Commissioning Heads, and PCT Chief Executives and commissioning directors. Through a series of strategic, action-led initiatives, the aims of APEX are to: - drive best practice and catalyse positive change for patients through practice-based commissioning; - translate the ideas of clinicians into successful plans for PCTs; - help strategic health authorities (SHAs), PCTs and practices turn "talk" into "action", and - demonstrate and pioneer models of collaboration between industry and the NHS. 2. APEX is sponsored by an unrestricted grant by Novartis Pharmaceuticals Ltd APEX


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):